3Miehielsen EC, Bakker JA, Kimmenade RR, et al. The diagnostic value of serum and urinary NT-proBNP for heart failure[ J]. Ann Clin Bio- chem, 2008,45 (4) : 389 -394.
4Jankowski M. B-type natriurefic peptide for diagnosis and therapy [ J ]. Recent Pat Cardiovase Drug Dis,2008,3 (2) :77 -83.
2Dorr M, Wolff B, Robinson DM, et al. The association of thyroid function with cantiac mass and left ventricular hypertrophy [ J ]. J Clin Endocrinol Metab, 2005, 90(2) :673-677.
3Danzi S, Klein I. Thyroid hormone and the cardiovascular system [J]. Minerva Endocrinol, 2004, 29(3) :139-150.
4Bernstein R, Midtbo K, Urdal P, et al. Serum N-termlnal pro-aterial factor 1-98 before and during thyroxine replacement therapy in severe hypothyroidism[J], Thyroid, 1997, 7(3) :415-419.
5Christ-Crain M, Morgenthaler NG, Meier C, et al. Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states [ J]. Swiss Med Wkly, 2005,135 (37-38) :549-554.
6Schultz M, Faber J, Kistorp C, et al. N-terminal-pro-B-type natriuretic peptid (NT-proBNP) in different thyroid states[ J]. Clin Endocrinol (Oxf), 2004, 60(1):54-59.
7Gheorghiade M, Bonow RO. Chronic heart failure in the United States. Circulation. 1998, 97(3):282.
8American society of echocardiography committee on standards, subcommittee on quantiffcation of two dimensional echocardiograms. Recommendations for quantification of the left ventricle by two - dimensional echocardiography. J Am Soc Echocardiogr. 1989, 2(5) :358.
9Beata Wozakowska- Kapton. Effect of sinus rhythm restoratoin on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol. 2004, 93(12) :1555.
10Inoue S, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Failure. 2000, 6(2) :92.
